Rizvi, Sumera
Khan, Shahid A.
Hallemeier, Christopher L.
Kelley, Robin K.
Gores, Gregory J.
Article History
First Online: 10 October 2017
Competing interests
: R.K.K has received research support from Agios, Eli Lilly, Merck, and Novartis, via her institution, for conduct of clinical trials in cholangiocarcinoma. S.R., S.A.K., C.L.H., and G.J.G. declare no competing interests.